US FDA approves Forest/Cypress's Savella for fibromyalgia - update
This article was originally published in Scrip
Executive Summary
The US FDAhas approved Forest Laboratoriesand Cypress Bioscience's SNRI Savella (milnacipran HCl) for the management of fibromyalgia. The companies expect Savella to be available in pharmacies by March.